Login

This is how a successful IT career began in Salzburg | Peter Belly, Managing Director, B+S Banksysteme AGDTD2X:GER 00:10:00

Share On Facebook Share On Twitter

Peter Belly is the managing director of B+S Banksysteme

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Jean Case: Revolutionizing Investments for Profit and Impact | Jean Case - CEO of The Case Foundation
00:10:00
creating something of true significance starts with seeing things|Morgan Beller,General Partner,NFX
00:10:00
American Politics and Historical Perspectives: Jaffa on Lincoln's Era|Harry Jaffa
00:10:00
2018 Market Outlook with Owen Fitzpatrick, Portfolio Manager at Aristotle Atlantic Partners
00:10:00
Maximizing Zinc Opportunities: Calannex's Strategic Advancements in Bathurst, New Brunswick
00:10:00
AdvTech Sees Continued Enrollment Growth Across Africa Amid High Demand for Quality Education | Roy Douglas, CEO, Advtech Ltd .
00:10:00
Prashant Kumar on Steering YES Bank Towards Growth and Stability | Prashant Kumar, CEO , Yes Bank Ltd.
00:10:00
Weekly Economic Update: Market Volatility, Fed Expectations, and Q2 Earnings
00:10:00
Black Venture Capitalists Confront Racism|Shauntel Garvey,Co-Founder and General Partner,Reach Capital
00:10:00
Expecting "plenty of news flow" from the JAC zone, AbraSilver Resource Corp. | John Miniotis, CEO, AbraSilver Resource CorpABRA:CVE
00:10:00
Exploring the benefits and risks of owner-financing in real estate transactions.
00:10:00
Max Boot on the History and Importance of Guerrilla Warfare

© 2017 - Neuhu+